ECM
TMO icon

Everence Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Everence Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.51M Buy
17,310
+821
+5% +$446K 0.52% 28
2025
Q4 		$9.55M Hold
16,489
– – 0.57% 26
2025
Q3 		$8M Buy
16,489
+30
+0.2% +$14K 0.48% 28
2025
Q2 		$6.67M Sell
16,459
-270
-2% -$113K 0.43% 33
2025
Q1 		$8.32M Sell
16,729
-1,790
-10% -$969K 0.57% 28
2024
Q4 		$9.63M Buy
18,519
+730
+4% +$401K 0.63% 26
2024
Q3 		$11M Sell
17,789
-670
-4% -$397K 0.69% 23
2024
Q2 		$10.5K Hold
18,459
– – 0.73% 22
2024
Q1 		$10.7K Hold
18,459
– – 0.71% 24
2023
Q4 		$9.8M Buy
18,459
+5,040
+38% +$2.44M 0.7% 23
2023
Q3 		$6.79K Hold
13,419
– – 0.53% 30
2023
Q2 		$6.82M Hold
13,419
– – 0.55% 29
2023
Q1 		$7.73K Sell
13,419
-630
-4% -$355K 0.63% 27
2022
Q4 		$7.74K Buy
14,049
+1,340
+11% +$710K 0.67% 27
2022
Q3 		$6.45M Sell
12,709
-2,790
-18% -$1.56M 0.6% 26
2022
Q2 		$8.42M Buy
15,499
+860
+6% +$473K 0.75% 20
2022
Q1 		$8.65M Buy
14,639
+1,890
+15% +$1.09M 0.66% 21
2021
Q4 		$8.51M Hold
12,749
– – 0.63% 20
2021
Q3 		$7.28M Hold
12,749
– – 0.6% 28
2021
Q2 		$6.43M Hold
12,749
– – 0.53% 32
2021
Q1 		$5.82M Hold
12,749
– – 0.53% 30
2020
Q4 		$5.94M Sell
12,749
-790
-6% -$370K 0.58% 28
2020
Q3 		$5.98M Sell
13,539
-1,580
-10% -$653K 0.66% 22
2020
Q2 		$5.28M Hold
15,119
– – 0.62% 22
2020
Q1 		$4.29M Buy
15,119
+990
+7% +$312K 0.6% 24
2019
Q4 		$4.59M Sell
14,129
-2,072
-13% -$628K 0.68% 22
2019
Q3 		$4.72M Hold
16,201
– – 0.76% 24
2019
Q2 		$4.76M Hold
16,201
– – 0.79% 23
2019
Q1 		$4.43M Buy
16,201
+4,572
+39% +$1.14M 0.77% 23
2018
Q4 		$2.6M Hold
11,629
– – 0.6% 37
2018
Q3 		$2.84M Hold
11,629
– – 0.56% 38
2018
Q2 		$2.41M Hold
11,629
– – 0.51% 44
2018
Q1 		$2.4M Hold
11,629
– – 0.53% 44
2017
Q4 		$2.21M Buy
11,629
+394
+4% +$75.5K 0.48% 49
2017
Q3 		$2.13M Hold
11,235
– – 0.49% 51
2017
Q2 		$1.96M Hold
11,235
– – 0.48% 46
2017
Q1 		$1.73M Hold
11,235
– – 0.45% 58
2016
Q4 		$1.58M Sell
11,235
-2,745
-20% -$405K 0.46% 57
2016
Q3 		$2.22M Hold
13,980
– – 0.66% 37
2016
Q2 		$2.07M Sell
13,980
-1,260
-8% -$186K 0.63% 39
2016
Q1 		$2.16M Buy
15,240
+1,150
+8% +$154K 0.67% 41
2015
Q4 		$2M Buy
14,090
+1,401
+11% +$187K 0.65% 42
2015
Q3 		$1.55M Hold
12,689
– – 0.54% 49
2015
Q2 		$1.65M Buy
12,689
+2,687
+27% +$350K 0.53% 49
2015
Q1 		$1.3M Buy
10,002
+970
+11% +$125K 0.44% 60
2014
Q4 		$1.13M Buy
9,032
+1,356
+18% +$165K 0.39% 74
2014
Q3 		$923K Hold
7,676
– – 0.34% 97
2014
Q2 		$906K Hold
7,676
– – 0.34% 97
2014
Q1 		$923K Hold
7,676
– – 0.36% 86
2013
Q4 		$855K Sell
7,676
-2,240
-23% -$223K 0.34% 94
2013
Q3 		$914K Hold
9,916
– – 0.39% 78
2013
Q2 		$839K Buy
+9,916
New +$825K 0.38% 81

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Everence Capital Management's TMO Position: Q1 2026 in Review

Everence Capital Management increased its Thermo Fisher Scientific (TMO) stake by 5% in Q1 2026, buying an estimated $446K and bringing the position to 17,310 shares worth $8.51M. The position accounts for 0.52% of the portfolio, ranked #28.

Everence Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $11M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Everence Capital Management held 17,310 shares of Thermo Fisher Scientific worth $8.51M as of Q1 2026.
  • Everence Capital Management bought 821 Thermo Fisher Scientific shares in Q1 2026, an estimated $446K.
  • Thermo Fisher Scientific made up 0.52% of Everence Capital Management's portfolio in Q1 2026, its #28 holding.
  • Everence Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Everence Capital Management's Thermo Fisher Scientific position peaked at $11M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.